First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders
Clinical trial NCT02719197 · COMPLETED
Trial details
- NCT number
- NCT02719197
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-19
- Primary completion
- 2016-12-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.